|Articles|August 3, 2022
How Decentralized Trials Accelerate Research and Enable Diversity
Author(s)Science 37
Decentralized clinical trials are not an all-or-nothing approach, they encompass a spectrum of hybrid designs that when implemented correctly deliver transformative results. In this white paper, Science 37 leaders discuss where decentralized research is now, and where we are headed. Experts unveil new—and proven— models and the benefits they deliver, from accelerated patient enrollment and improved experience to real-world representation.
Trending on Applied Clinical Trials Online
1
Recruitment in the Age of AI: Q&A with John Worden, Javara
2
What It Actually Means to Embed the Patient Voice in Trial Design
3
What This Study Means for Sponsors Still Struggling to Justify RBQM at Scale
4
Why Seizure Counts Alone Can't Define Success in Epilepsy Trials
5